BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15371750)

  • 21. L-allylglycine dissociates the neural substrates of fear in the periaqueductal gray of rats.
    Cunha JM; Zanoveli JM; Ledvinka-Filho E; Brandão ML
    Brain Res Bull; 2010 Mar; 81(4-5):416-23. PubMed ID: 19800953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lidocaine blockade of amygdala output in fear-conditioned rats reduces Fos expression in the ventrolateral periaqueductal gray.
    Carrive P; Lee J; Su A
    Neuroscience; 2000; 95(4):1071-80. PubMed ID: 10682714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of NK1 receptors of the amygdala on the processing of different types of fear.
    Carvalho MC; Santos JM; Bassi GS; Brandão ML
    Neurobiol Learn Mem; 2013 May; 102():20-7. PubMed ID: 23567110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety.
    Brenes JC; Broiz AC; Bassi GS; Schwarting RK; Brandão ML
    Braz J Med Biol Res; 2012 Apr; 45(4):349-56. PubMed ID: 22392188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lesions of amygdaloid nuclei and substantia nigra on aversive responses induced by electrical stimulation of the inferior colliculus.
    Maisonnette SS; Kawasaki MC; Coimbra NC; Brandão ML
    Brain Res Bull; 1996; 40(2):93-8. PubMed ID: 8724425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dorsal periaqueductal gray lesion on cardiovascular and behavioural responses to contextual conditioned fear in rats.
    Leman S; Dielenberg RA; Carrive P
    Behav Brain Res; 2003 Aug; 143(2):169-76. PubMed ID: 12900043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral sensitization induced by dorsal periaqueductal gray electrical stimulation is counteracted by NK1 receptor antagonism in the ventral hippocampus and central nucleus of the amygdala.
    Carvalho MC; Veloni AC; Genaro K; Brandão ML
    Neurobiol Learn Mem; 2018 Feb; 148():60-68. PubMed ID: 29519453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term full kindling of the amygdala dissociates natural and periaqueductal gray-evoked flight behaviors of the rat.
    Tannure RM; Bittencourt AS; Schenberg LC
    Behav Brain Res; 2009 May; 199(2):247-56. PubMed ID: 19103230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in extracellular levels of gamma-aminobutyric acid in the rat basolateral amygdala and periaqueductal gray during conditioned fear, persistent pain and fear-conditioned analgesia.
    Rea K; Lang Y; Finn DP
    J Pain; 2009 Oct; 10(10):1088-98. PubMed ID: 19729347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The indirect amygdala-dorsal striatum pathway mediates conditioned freezing: insights on emotional memory networks.
    Ferreira TL; Shammah-Lagnado SJ; Bueno OF; Moreira KM; Fornari RV; Oliveira MG
    Neuroscience; 2008 Apr; 153(1):84-94. PubMed ID: 18367339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared Dorsal Periaqueductal Gray Activation Patterns during Exposure to Innate and Conditioned Threats.
    Reis FMCV; Liu J; Schuette PJ; Lee JY; Maesta-Pereira S; Chakerian M; Wang W; Canteras NS; Kao JC; Adhikari A
    J Neurosci; 2021 Jun; 41(25):5399-5420. PubMed ID: 33883203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal dopamine attenuates fear responses induced by electric shock to the foot and by electrical stimulation of the dorsal periaqueductal gray matter.
    de Carvalho MC; Figueiredo RM; Coimbra NC; Leite-Panissi CRA; de Souza Silva MA; Huston JP; Mattern C; Brandão ML
    J Psychopharmacol; 2019 Dec; 33(12):1524-1532. PubMed ID: 31328620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdala and periaqueductal gray lesions only partially attenuate unconditional defensive responses in rats exposed to a cat.
    de Oca BM; Fanselow MS
    Integr Physiol Behav Sci; 2004; 39(4):318-33. PubMed ID: 16295774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm.
    Fendt M; Koch M; Schnitzler HU
    Behav Brain Res; 1996 Jan; 74(1-2):127-34. PubMed ID: 8851921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic sites responding to predator threats--the role of the dorsal premammillary nucleus in unconditioned and conditioned antipredatory defensive behavior.
    Cezario AF; Ribeiro-Barbosa ER; Baldo MV; Canteras NS
    Eur J Neurosci; 2008 Sep; 28(5):1003-15. PubMed ID: 18691328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective involvement of GABAergic mechanisms of the dorsal periaqueductal gray and inferior colliculus on the memory of the contextual fear as assessed by the fear potentiated startle test.
    Reimer AE; Oliveira AR; Brandão ML
    Brain Res Bull; 2008 Jul; 76(5):545-50. PubMed ID: 18534264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear.
    Kim JJ; Rison RA; Fanselow MS
    Behav Neurosci; 1993 Dec; 107(6):1093-8. PubMed ID: 8136063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamatergic mechanisms of the dorsal periaqueductal gray matter modulate the expression of conditioned freezing and fear-potentiated startle.
    Reimer AE; de Oliveira AR; Brandão ML
    Neuroscience; 2012 Sep; 219():72-81. PubMed ID: 22698693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional mapping of the circuits involved in the expression of contextual fear responses in socially defeated animals.
    Faturi CB; Rangel MJ; Baldo MV; Canteras NS
    Brain Struct Funct; 2014 May; 219(3):931-46. PubMed ID: 23546547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fear state induced by ethanol withdrawal may be due to the sensitization of the neural substrates of aversion in the dPAG.
    Cabral A; Isoardi N; Salum C; Macedo CE; Nobre MJ; Molina VA; Brandão ML
    Exp Neurol; 2006 Jul; 200(1):200-8. PubMed ID: 16624300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.